Alzheimer Archives - Institute for Bioengineering of Catalonia

November 23, 2023

Benedetta Bolognesi awarded a prestigious European ERC Consolidator Grant

The researcher at the Institute for Bioengineering of Catalonia has been awarded an ERC Consolidator Grant. This prestigious European funding supports excellent scientists and scholars who are consolidating their independent research teams to pursue their most promising scientific ideas. The €2 million grant over 5 years will allow Bolognesi and her team to develop a new method for identifying mutations that lead to the formation of amyloids—aggregates of proteins that contribute to a variety of diseases, including Alzheimer’s and Parkinson’s.

March 30, 2023March 29, 2023

The “la Caixa” Foundation will fund a large and innovative research project co-led by IBEC Junior Group Leader Benedetta Bolognesi and by ICREA research professor Ben Lehner at CRG, which aims to gain a better understanding of the genetic causes leading to neurodegenerative diseases. Researchers will combine deep mutagenesis and machine learning techniques to produce a “map of dementia” as a method to predict whether a person is more susceptible to suffer these diseases.

March 22, 2021March 15, 2021

One more step towards early detection of Alzheimer’s

Benedetta Bolognesi, junior group leader at IBEC, appears in different media for a recent study published in the eLife magazine. In the study they show the first map with all the possible mutations in the amyloid beta peptide and tested how they influence its aggregation into plaques, a pathological hallmark of Alzheimer’s disease.

March 9, 2021March 9, 2021

First comprehensive map of amyloid plaque mutations opens new avenues for early detection of Alzheimer’s disease

A study published in the journal eLife made all the possible mutations in the amyloid beta peptide and tested how they influence its aggregation into plaques, a pathological hallmark of Alzheimer’s disease.

Benedetta Bolognesi awarded a prestigious European ERC Consolidator Grant

A blood-brain barrier on a chip to study drugs against Alzheimer’s

A new atlas unveils which mutations are behind the noxious amyloid formation

Benedetta Bolognesi and Ben Lehner win competitive funding to join forces against neurodegenerative diseases

One more step towards early detection of Alzheimer’s

First comprehensive map of amyloid plaque mutations opens new avenues for early detection of Alzheimer’s disease

A study published in the journal eLife made all the possible mutations in the amyloid beta peptide and tested how they influence its aggregation into plaques, a pathological hallmark of Alzheimer’s disease.